Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Study Record Dates now displays 'Last Update Posted (Estimated)' instead of 'Last Update Posted'; the underlying timestamp data are unchanged.
    Difference
    0.0%
    Check dated 2025-12-24T23:32:53.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    New study sites were added: New Cross Hospital, Wolverhampton, UK, and Adana Baskent University Medical Faculty, Adana, Türkiye. The total number of study locations is updated to 127, and related details such as the completion date and EU CTIS number were updated.
    Difference
    2%
    Check dated 2025-12-17T19:51:04.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows revision v3.3.2, replacing the previous revision v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-26T08:37:32.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removed the site-wide notice about a lapse in government funding and the related operating-status guidance. The notice previously stated that information may not be up to date and directed users to cc.nih.gov and opm.gov for status updates.
    Difference
    0.2%
    Check dated 2025-11-19T08:08:17.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The screenshots show the same study details page with no substantive differences in the study design, eligibility criteria, interventions, or outcomes; any differences appear to be minor or cosmetic edits that do not affect the page’s primary purpose. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T02:43:09.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Core content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.
    Difference
    2%
    Check dated 2025-10-06T15:51:20.000Z thumbnail image

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.